Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Post

Showing results (351-360 of 535) with videos related to

Pageof 54
Sort By:
AIDS (London, England)|February 14, 2018
Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individualsBorja Mora-Peris, George Bouliotis, Kulasegaram Ranjababu, et al.
The Journal of Infectious Diseases|June 15, 2004
Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosisFrank A Post, Paul A Willcox, Barun Mathema, et al.
Pharmacogenetics and Genomics|April 26, 2023
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern AfricansSomila Mateza, Yuki Bradford, Gary Maartens, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2013
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort studyDavid I Dolling, David T Dunn, Katherine A Sutherland, et al.
International Journal of STD & AIDS|June 9, 2021
Use of β-D-glucan in diagnosis of suspected <i>Pneumocystis jirovecii</i> pneumonia in adults with HIV infectionThomas Juniper, Chris P Eades, Eliza Gil, et al.
HIV Clinical Trials|March 18, 2017
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial<sup/>Frank A Post, Yazdan Yazdanpanah, Gabriel Schembri, et al.
Scientific Reports|March 15, 2025
Floodplain inundation in the Murray-Darling Basin under current and future climate conditionsJin Teng, Francis H S Chiew, Hongxing Zheng, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Automation of high-throughput arrayed lentivirus production and titrationChih-Cheng Yang, Aniruddha J Deshpande, Michael Jackson, et al.
AIDS (London, England)|April 30, 2021
Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United KingdomRachel Hung, Nisha Patel, Julie Fox, et al.
HIV Medicine|October 28, 2016
Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIVJ Underwood, D De Francesco, F A Post, et al.
Pageof 54

Showing results (351-360 of 535) with videos related to

Sort By:
Pageof 54
AIDS (London, England)|February 14, 2018
Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individualsBorja Mora-Peris, George Bouliotis, Kulasegaram Ranjababu, et al.
The Journal of Infectious Diseases|June 15, 2004
Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosisFrank A Post, Paul A Willcox, Barun Mathema, et al.
Pharmacogenetics and Genomics|April 26, 2023
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern AfricansSomila Mateza, Yuki Bradford, Gary Maartens, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2013
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort studyDavid I Dolling, David T Dunn, Katherine A Sutherland, et al.
International Journal of STD & AIDS|June 9, 2021
Use of β-D-glucan in diagnosis of suspected <i>Pneumocystis jirovecii</i> pneumonia in adults with HIV infectionThomas Juniper, Chris P Eades, Eliza Gil, et al.
HIV Clinical Trials|March 18, 2017
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial<sup/>Frank A Post, Yazdan Yazdanpanah, Gabriel Schembri, et al.
Scientific Reports|March 15, 2025
Floodplain inundation in the Murray-Darling Basin under current and future climate conditionsJin Teng, Francis H S Chiew, Hongxing Zheng, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Automation of high-throughput arrayed lentivirus production and titrationChih-Cheng Yang, Aniruddha J Deshpande, Michael Jackson, et al.
AIDS (London, England)|April 30, 2021
Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United KingdomRachel Hung, Nisha Patel, Julie Fox, et al.
HIV Medicine|October 28, 2016
Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIVJ Underwood, D De Francesco, F A Post, et al.
Pageof 54